Return to study ST003245 main page

Download data matrix(Exploration of Zeb1-dependent changes in the lipidome of MDA-MB-231 cells Reversed phase NEGATIVE ION MODE)

AnalysisSamplesFactorsUnits
Reversed phase NEGATIVE ION MODE190905_AG_Brabletz_ZEB1_EMT_Lipidomics__shGFP_#1_1Sample source:Breast cancer cell line | Genotype:control for Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE190905_AG_Brabletz_ZEB1_EMT_Lipidomics__shGFP_#1_2Sample source:Breast cancer cell line | Genotype:control for Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE190905_AG_Brabletz_ZEB1_EMT_Lipidomics__shGFP_#1_3Sample source:Breast cancer cell line | Genotype:control for Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE190905_AG_Brabletz_ZEB1_EMT_Lipidomics__shGFP_#4_1Sample source:Breast cancer cell line | Genotype:control for Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE190905_AG_Brabletz_ZEB1_EMT_Lipidomics__shGFP_#4_2Sample source:Breast cancer cell line | Genotype:control for Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE190905_AG_Brabletz_ZEB1_EMT_Lipidomics__shGFP_#4_3Sample source:Breast cancer cell line | Genotype:control for Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE210514_MDA_ZEB1_n1_2h_sh-Ctrl_DMSO_4Sample source:Breast cancer cell line | Genotype:control for Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE210514_MDA_ZEB1_n2_2h_sh-Ctrl_DMSO_13Sample source:Breast cancer cell line | Genotype:control for Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE210514_MDA_ZEB1_n3_2h_sh-Ctrl_DMSO_22Sample source:Breast cancer cell line | Genotype:control for Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE220408_MDA shCtrl_1_10_PC_5Sample source:Breast cancer cell line | Genotype:control for Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE220408_MDA shCtrl_1_10_PC_6Sample source:Breast cancer cell line | Genotype:control for Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE220408_MDA shCtrl_1_10_PC_7Sample source:Breast cancer cell line | Genotype:control for Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE220408_MDA shCtrl_1_10_PC_8Sample source:Breast cancer cell line | Genotype:control for Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE220408_MDA shZEB1_1_10_PE_5Sample source:Breast cancer cell line | Genotype:control for Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE220408_MDA shZEB1_1_10_PE_6Sample source:Breast cancer cell line | Genotype:control for Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE220408_MDA shZEB1_1_10_PE_7Sample source:Breast cancer cell line | Genotype:control for Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE220408_MDA shZEB1_1_10_PE_8Sample source:Breast cancer cell line | Genotype:control for Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE230309_shCTRL shZEB1_Rao_shCTRL_5Sample source:Breast cancer cell line | Genotype:control for Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE230309_shCTRL shZEB1_Rao_shCTRL_6Sample source:Breast cancer cell line | Genotype:control for Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE230309_shCTRL shZEB1_Rao_shCTRL_7Sample source:Breast cancer cell line | Genotype:control for Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE230309_shCTRL shZEB1_Rao_shCTRL_8Sample source:Breast cancer cell line | Genotype:control for Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE190905_AG_Brabletz_ZEB1_EMT_Lipidomics__MDA_MB_231_WT_1Sample source:Breast cancer cell line | Genotype:Wild-typerelative intensities
Reversed phase NEGATIVE ION MODE190905_AG_Brabletz_ZEB1_EMT_Lipidomics__MDA_MB_231_WT_2Sample source:Breast cancer cell line | Genotype:Wild-typerelative intensities
Reversed phase NEGATIVE ION MODE190905_AG_Brabletz_ZEB1_EMT_Lipidomics__MDA_MB_231_WT_3Sample source:Breast cancer cell line | Genotype:Wild-typerelative intensities
Reversed phase NEGATIVE ION MODE210514_MDA_ZEB1_n1_2h_WT_DMSO_1Sample source:Breast cancer cell line | Genotype:Wild-typerelative intensities
Reversed phase NEGATIVE ION MODE210514_MDA_ZEB1_n2_2h_WT_DMSO_10Sample source:Breast cancer cell line | Genotype:Wild-typerelative intensities
Reversed phase NEGATIVE ION MODE210514_MDA_ZEB1_n3_2h_WT_DMSO_19Sample source:Breast cancer cell line | Genotype:Wild-typerelative intensities
Reversed phase NEGATIVE ION MODE190905_AG_Brabletz_ZEB1_EMT_Lipidomics__shZEB1#13_1Sample source:Breast cancer cell line | Genotype:Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE190905_AG_Brabletz_ZEB1_EMT_Lipidomics__shZEB1#13_2Sample source:Breast cancer cell line | Genotype:Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE190905_AG_Brabletz_ZEB1_EMT_Lipidomics__shZEB1#13_3Sample source:Breast cancer cell line | Genotype:Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE190905_AG_Brabletz_ZEB1_EMT_Lipidomics__shZEB1#F10_1Sample source:Breast cancer cell line | Genotype:Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE190905_AG_Brabletz_ZEB1_EMT_Lipidomics__shZEB1#F10_2Sample source:Breast cancer cell line | Genotype:Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE190905_AG_Brabletz_ZEB1_EMT_Lipidomics__shZEB1#F10_3Sample source:Breast cancer cell line | Genotype:Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE210514_MDA_ZEB1_n1_2h_sh-ZEB1_DMSO_7Sample source:Breast cancer cell line | Genotype:Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE210514_MDA_ZEB1_n2_2h_sh-ZEB1_DMSO_16Sample source:Breast cancer cell line | Genotype:Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE210514_MDA_ZEB1_n3_2h_sh-ZEB1_DMSO_25Sample source:Breast cancer cell line | Genotype:Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE220408_MDA shCtrl_1_10_PE_1Sample source:Breast cancer cell line | Genotype:Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE220408_MDA shCtrl_1_10_PE_2Sample source:Breast cancer cell line | Genotype:Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE220408_MDA shCtrl_1_10_PE_3Sample source:Breast cancer cell line | Genotype:Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE220408_MDA shCtrl_1_10_PE_4Sample source:Breast cancer cell line | Genotype:Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE220408_MDA shZEB1_1_10_PC_1Sample source:Breast cancer cell line | Genotype:Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE220408_MDA shZEB1_1_10_PC_2Sample source:Breast cancer cell line | Genotype:Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE220408_MDA shZEB1_1_10_PC_3Sample source:Breast cancer cell line | Genotype:Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE220408_MDA shZEB1_1_10_PC_4Sample source:Breast cancer cell line | Genotype:Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE230309_shCTRL shZEB1_Rao_shZEB1_1Sample source:Breast cancer cell line | Genotype:Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE230309_shCTRL shZEB1_Rao_shZEB1_2Sample source:Breast cancer cell line | Genotype:Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE230309_shCTRL shZEB1_Rao_shZEB1_3Sample source:Breast cancer cell line | Genotype:Zeb1 stable knockdownrelative intensities
Reversed phase NEGATIVE ION MODE230309_shCTRL shZEB1_Rao_shZEB1_4Sample source:Breast cancer cell line | Genotype:Zeb1 stable knockdownrelative intensities
  logo